241 related articles for article (PubMed ID: 25437864)
21. Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment.
Annan DA; Maishi N; Soga T; Dawood R; Li C; Kikuchi H; Hojo T; Morimoto M; Kitamura T; Alam MT; Minowa K; Shinohara N; Nam JM; Hida Y; Hida K
Cell Commun Signal; 2019 Dec; 17(1):169. PubMed ID: 31847904
[TBL] [Abstract][Full Text] [Related]
22. Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma.
Yanagiya M; Dawood RIH; Maishi N; Hida Y; Torii C; Annan DA; Kikuchi H; Yanagawa Matsuda A; Kitamura T; Ohiro Y; Shindoh M; Tanaka S; Kitagawa Y; Hida K
Pathol Int; 2021 Jun; 71(6):383-391. PubMed ID: 33783897
[TBL] [Abstract][Full Text] [Related]
23. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
24. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
[TBL] [Abstract][Full Text] [Related]
25. Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.
Maishi N; Ohba Y; Akiyama K; Ohga N; Hamada J; Nagao-Kitamoto H; Alam MT; Yamamoto K; Kawamoto T; Inoue N; Taketomi A; Shindoh M; Hida Y; Hida K
Sci Rep; 2016 Jun; 6():28039. PubMed ID: 27295191
[TBL] [Abstract][Full Text] [Related]
26. Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.
Yamamoto K; Ohga N; Hida Y; Maishi N; Kawamoto T; Kitayama K; Akiyama K; Osawa T; Kondoh M; Matsuda K; Onodera Y; Fujie M; Kaga K; Hirano S; Shinohara N; Shindoh M; Hida K
Br J Cancer; 2012 Mar; 106(6):1214-23. PubMed ID: 22374465
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
Rofstad EK; Halsør EF
Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
[TBL] [Abstract][Full Text] [Related]
28. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
30. Effects of combretastatin A-4 phosphate on canine normal and tumor tissue-derived endothelial cells.
Izumi Y; Aoshima K; Hoshino Y; Takagi S
Res Vet Sci; 2017 Jun; 112():222-228. PubMed ID: 28527400
[TBL] [Abstract][Full Text] [Related]
31. Contribution of Tumor Endothelial Cells in Cancer Progression.
Hida K; Maishi N; Annan DA; Hida Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
[TBL] [Abstract][Full Text] [Related]
32. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
[TBL] [Abstract][Full Text] [Related]
33. IL-3 is a novel target to interfere with tumor vasculature.
Dentelli P; Rosso A; Olgasi C; Camussi G; Brizzi MF
Oncogene; 2011 Dec; 30(50):4930-40. PubMed ID: 21643009
[TBL] [Abstract][Full Text] [Related]
34. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.
Kadenhe-Chiweshe A; Papa J; McCrudden KW; Frischer J; Bae JO; Huang J; Fisher J; Lefkowitch JH; Feirt N; Rudge J; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Res; 2008 Jan; 6(1):1-9. PubMed ID: 18234958
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
36. Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.
Zhang T; Sun HC; Zhou HY; Luo JT; Zhang BL; Wang P; Wang L; Qin LX; Ren N; Ye SL; Li Q; Tang ZY
Cancer Lett; 2010 Apr; 290(2):204-10. PubMed ID: 19822391
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of canine tumor endothelial cells.
Izumi Y; Hoshino Y; Hosoya K; Takagi S; Okumura M
J Vet Med Sci; 2015 Mar; 77(3):359-63. PubMed ID: 25482496
[TBL] [Abstract][Full Text] [Related]
38. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
[TBL] [Abstract][Full Text] [Related]
39. Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice.
Yang H; Lee S; Lee S; Kim K; Yang Y; Kim JH; Adams RH; Wells JM; Morrison SJ; Koh GY; Kim I
J Clin Invest; 2013 Jan; 123(1):418-31. PubMed ID: 23241958
[TBL] [Abstract][Full Text] [Related]
40. VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner.
Vartanian A; Stepanova E; Grigorieva I; Solomko E; Baryshnikov A; Lichinitser M
Melanoma Res; 2011 Apr; 21(2):91-8. PubMed ID: 21389833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
